 Home > Medical News > Latest Medical News > The price of raw materials for Lianhua Qingwen has skyrocketed, and ensuring production is the top priority!

The price of raw materials for Lianhua Qingwen has skyrocketed, and ensuring production is the top priority!

 Last Update: 2022-12-30
 Source: Internet
 Author: User

Tags

counter ed medicine

rotella 15 40

online periodic table

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

According to the third quarterly report of 2022 released by Shijiazhuang Yiling Pharmaceutical Co.
, Ltd.
(Yiling Pharmaceutical, 002603), in the first three quarters, the company achieved operating income of 7.
946 billion yuan, down 2.
04% year-on-year, net profit attributable to owners was 1.
414 billion yuan, a year-on-year increase of 15.
58%, and net profit attributable to non-owners was 1.
416 billion yuan, a year-on-year increase of 20.
60%.

Figure 1: Core operating data of Yiling Pharmaceutical from 2016 to 2022

First, Lianhua Qingwen and other anti-epidemic traditional Chinese medicines have aroused great concern

Cold respiratory medicine is one of
the core categories of Ling Pharmaceutical.
According to data from Minai.
com, in 2019, the sales scale of proprietary drugs in the respiratory system exceeded 40 billion, with a compound growth rate of 4.
52%, and sales affected by the epidemic fell by 29.
63% in 2020, and achieved a recovery growth of 13.
09% in 2021; Among them, the sales scale of subdivided sub-cold drugs maintained rapid growth, with a compound growth of 10.
08% from 2015 to 2019, significantly higher than that of respiratory drugs, and sales fell by 6.
45% in 2020, much lower than respiratory drugs, with an increase of 19.
23%
in 2021.

Among them, Lianhua Qingwen's market share has maintained rapid growth, especially in April 2020, Lianhua Qingwen was approved to add a new indication of "new coronavirus pneumonia mild and ordinary type", which was widely used in epidemic prevention and control, and its market share in the public hospital channel reached 33.
5% in 2020 and increased to 41.
8%
in 2021.

In November 2022, after the promulgation of the "New Ten Rules" for epidemic prevention and control, due to the emergence of a large number of Omicron infected people in stages and the intensification of people's panic in the short term, there was a "hoarding tide", and anti-epidemic proprietary Chinese medicines such as Lianhua Qingwen were difficult to find in retail pharmacies, and enterprises needed to dispatch raw materials to step up production, driving the price of some anti-epidemic Chinese medicine raw materials to skyrocket.

In this issue, the big data platform of Tiandi Cloud Map Chinese Medicine Industry analyzes the cost pressure of traditional Chinese medicine raw materials faced by enterprises from the perspective of raw materials involved in Lianhua Qingwen
.

Second, the core raw materials of Lianhua Qingwen capsules

Table 1: Core ingredients of Lianhua Qingwen capsules

Third, the rise and fall of raw materials of Lianhua Qingwen capsules

Table 2: Rise and fall table of raw materials of Lianhua Qingwen capsules (: yuan/kg)

From January 2022 to December 2022, the core raw materials of Lianhua Qingwen capsules increased 11 varieties, accounting for 84.
6%, and 2 flat varieties, accounting for 15.
4%.

Fourth, Lianhua Qingwen capsule raw material market comment

Forsythia, due to the high price caused farmers to harvest cautiously, the transaction volume is not as good as the previous period, but the market small batch of goods moving smoothly, the market continues to rise, the holder is reluctant to sell, the market general price is between 250-260 yuan (kilogram price, the same below), good goods shouting price of about 280 yuan, it is expected that there may be violent fluctuations in the short term
.

Honeysuckle, with the recent source of goods moving smoothly, coupled with the rising market of origin, the market holding merchants also continue to raise prices, the market changes several times a day, now Shandong white flower prices between 250-260 yuan, the market inventory is not much, the holders are reluctant to sell, the market will not be calm
.

Almonds, the source of goods is tight, the market is rising, the market is also driven by demand recently, the source of goods is sold smoothly, the market performance is strong, the current market bitter almond price is between 35-37 yuan, the market is rising rapidly, the market pays attention to the source of sales
.

Gypsum, market demand increases, recently there are merchants to purchase large goods, the source of goods purchase and sales continue to be smooth, and the market has risen sharply, the current market unified goods asking price in 5-6 yuan, with the consumption of inventory, once the market source can not be effectively replenished, the market may change
.

Banlangen, high prices lead to market trading volume is not as good as the previous period, these days sales have decreased compared with previous days, and the market stopped rising temporarily stabilized, the market is now a unified price between 25-26 yuan, the current market supply is not abundant, with the consumption of inventory, merchant attention will change
.

Mianma Guanzhong, the source of origin is not easy to organize, market inventory consumption, coupled with the strengthening of the selling psychology of cargo holders, the price has risen steadily, and the current asking price of Mianma Guanzhong's goods in the northeast of the market ranges from 27-30 yuan
.

patchouli, patchouli production new basically ended, the early low price led to this year's production decrease, recently due to the epidemic, market transactions are mainly small batches, the current merchants in the hands of inventory continue to decline, the market rose again, the price of cut goods is between 33-35 yuan, some of the pre-prepared merchants gradually
shipped.

5.
Comprehensive comments

1.
The procurement cost pressure of raw materials such as patchouli and forsythia is greater The raw material pressure test shows that the current raw materials of Lianhua Qingwen capsules are mainly from patchouli, forsythia, Mianma Guanzhong, etc.
from the perspective of supply pressure; From the perspective of quality pressure, it mainly comes from forsythia, Mianma Guanzhong, menthol and so on
.

2.
The price of 7 raw materials of Lianhua Qingwen capsules has more than doubled Since the domestic epidemic control was liberalized, the market of raw materials of Lianhua Qingwen capsules has begun to rise sharply, such as patchouli prices have increased by more than 200%; Forsythia and Mianma Guanzhong's price increase by more than 150%; Other varieties with low price increases such as menthol and rhubarb, in the case of increased attention, fast supply, and merchants reluctant to sell, there will be a possibility of a sharp rise in the future
.

3.
Short-term demand has soared, and e-commerce platforms have increased prices Yiling Pharmaceutical's Lianhua Qingwen series of epidemic prevention proprietary Chinese medicines have gradually become the largest brand
of proprietary Chinese medicines for cold in the retail market.
The expansion of market share will also drive the hot sales of its various products, and the growth rate of corporate revenue will rise steadily
.
With the continuation of the global new crown epidemic, it is foreseeable that the sales of Yiling Pharmaceutical's leading products will continue to improve
.
The official flagship store of Yiling Pharmaceutical can still see Lianhua Qingwen capsules priced at 14.
8 yuan / box, but the product has been removed
.
However, on the e-commerce platform, the price of the same capsule has reached 68 yuan, an increase of more than 3 times
.

In summary, in the short term, the market of raw materials of Lianhua Qingwen capsules has soared, bringing greater pressure to the company's operation, and it is suggested that Yiling Pharmaceutical should continue to strengthen information monitoring and market monitoring, reasonably adjust the inventory of raw materials, and also pay attention to the long-term sustainable supply of wild medicinal raw materials, so as to timely avoid uncontrollable
costs caused by unstable supply of raw materials.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.